Medroxyprogesterone 17-acetate
SIGMA/M1629 - ≥97% (HPLC)
Synonym: 17α-Acetoxy-6α-methylprogesterone; 17α-Hydroxy-6α-methyl-4-pregnene-3,20-dione 17-acetate; 6α-Methyl-17α-acetoxyprogesterone; 6α-Methyl-17α-hydroxyprogesterone acetate
CAS Number: 71-58-9
Empirical Formula (Hill Notation): C24H34O4
Molecular Weight: 386.52
EC Number: 200-757-9
MDL Number: MFCD00010483
Linear Formula: C24H34O4
Product Type: Chemical
| assay | ≥97% (HPLC) |
| biological source | synthetic (organic) |
| form | powder |
| InChI | 1S/C24H34O4/c1-14-12-18-1 |
| InChI key | PSGAAPLEWMOORI-PEINSRQWSA |
| mp | 206-207 °C (lit.) |
| Quality Level | 100 ![]() |
| shipped in | ambient |
| SMILES string | [H][C@@]12C[C@H](C)C3=CC( |
| solubility | chloroform: 350 mg/mL, clear, colorless |
| sterility | non-sterile |
| storage temp. | room temp |
| Biochem/physiol Actions: | Medroxyprogesterone 17-acetate (MPA) is a synthetic progestin used as a contraceptive, in hormone replacement therapy and for the treatment of endometriosis. It is a more potent progestin that the nonacetylated form. |
| Features and Benefits: | This compound is featured on the Nuclear Receptors (Steroids) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 1, 10 g in glass bottle |
| Symbol | GHS08 |
| Signal word | Warning |
| Hazard statements | H351 |
| Precautionary statements | P281 |
| Hazard Codes | Xn |
| Risk Statements | 40-48 |
| Safety Statements | 22-36/37/39-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| mp | 206-207 °C (lit.) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |


